 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
1xzz
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Membrane protein
|
 |
|
Title:
|
 |
Crystal structure of the ligand binding suppressor domain of inositol 1,4,5-trisphosphate receptor
|
|
Structure:
|
 |
Inositol 1,4,5-trisphosphate receptor type 1. Chain: a. Fragment: ip3r suppressor domain (residues 2-223). Synonym: type 1 inositol 1,4,5- trisphosphate receptor, typ receptor, ip3 receptor isoform 1, insp3r1, inositol 1,4,5- trisphosphate-binding protein p400, purkinje cell protein 1 pcd-6. Engineered: yes
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Gene: itpr1, insp3r, pcd6, pcp1. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
1.80Å
|
R-factor:
|
0.205
|
R-free:
|
0.238
|
|
|
Authors:
|
 |
I.Bosanac,H.Yamazaki,T.Matsu-Ura,T.Michikawa,K.Mikoshiba,M.I
|
Key ref:
|
 |
I.Bosanac
et al.
(2005).
Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor.
Mol Cell,
17,
193-203.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Nov-04
|
Release date:
|
25-Jan-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
|
|
P11881
(ITPR1_MOUSE) -
Inositol 1,4,5-trisphosphate receptor type 1
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2749 a.a.
216 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 5 residue positions (black
crosses)
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
2 terms
|
 |
|
Biological process
|
calcium ion transport
|
1 term
|
 |
|
Biochemical function
|
inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Mol Cell
17:193-203
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor.
|
|
I.Bosanac,
H.Yamazaki,
T.Matsu-Ura,
T.Michikawa,
K.Mikoshiba,
M.Ikura.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Binding of inositol 1,4,5-trisphosphate (IP(3)) to the amino-terminal region of
IP(3) receptor promotes Ca(2+) release from the endoplasmic reticulum. Within
the amino terminus, the first 220 residues directly preceding the IP(3) binding
core domain play a key role in IP(3) binding suppression and regulatory protein
interaction. Here we present a crystal structure of the suppressor domain of the
mouse type 1 IP(3) receptor at 1.8 A. Displaying a shape akin to a hammer, the
suppressor region contains a Head subdomain forming the beta-trefoil fold and an
Arm subdomain possessing a helix-turn-helix structure. The conserved region on
the Head subdomain appeared to interact with the IP(3) binding core domain and
is in close proximity to the previously proposed binding sites of Homer, RACK1,
calmodulin, and CaBP1. The present study sheds light onto the mechanism
underlying the receptor's sensitivity to the ligand and its communication with
cellular signaling proteins.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Structure of Mouse IP[3]R[sup](A) Ribbon diagram
of the IP[3]R[sup] Head subdomain (green) and Arm subdomain
(yellow).(B) View in (A) rotate by 90°.(C) Section of
experimental electron density map contoured at 2.5σ in
stereoview.(D) The IP[3]R[sup] (yellow) is superimposed on the
β-domain of the IP[3]R[core] (cyan) (PDB accession number 1N4K,
residues 236–436). The splice site SI is shown in β-domain of
the IP[3]R[core]. The rmsd of the superposition is 2.0 Å.
Panels were generated with MOLSCRIPT (Kraulis, 1991), Raster3D
(Merrit and Bacon, 1997), and CONSCRIPT software (Lawrence and
Bourke, 2000).
|
 |
Figure 5.
Figure 5. Modeling of β-Trefoil Domains in hRyR1(A)
Structure-based sequence alignment between mIP[3]R1 and hRyR1.
Location of the 12 β strands in the two β-trefoil domains of
hRyR1 is depicted. Residues within the β strands of the two
β-trefoil domains in mIP[3]R1 (IP3R-βD1 and IP3R-βD2) and
hRyR1 (RyR-βD1 and RyR-βD2) are shown. Residues comprising the
linker regions are not shown. Key residues at the interior of
the β-trefoil barrel are arranged in three layers referred to
as bottom (highlighted in yellow), middle (highlighted in blue),
and top (highlighted in green) (Murzin et al., 1992). The bottom
layer is comprised of residues just underneath the triangular
cap, with the middle and top layers lying parallel to it and
away from the cap. The key residues of the triangular cap
(highlighted in gray) interact with the residues from the bottom
layer of the barrel. Residues of hRyR1 whose mutations lead to
MH and CCD are shown in red.(B) Modeled structure of first
β-trefoil domain in hRyR1 (RyR-βD1) based on the sequence
alignment shown in (A). The model is shown as ribbon diagram in
a top panel, with MH and CCD mutations highlighted in red.
Surface electrostatic potential, with positive charge depicted
in blue and negative charge in red, is plotted in the middle
panel. The bottom panel shows surface residue conservation
determined from sequence alignment of RyR receptors listed
below, with identical residues in magenta and the least
conserved residues in green. The highly conserved area (residues
R75, Q79, Q93, T99, Y102, R124, D128, K129, L130, F132, T148,
H150, P151, A152, S153, K154, Q155, S157, E158, E160, K161,
R163, I169, V171, S172, V173, E176, R177, Y178, F194) is
observed only on this side of the molecule.(C) View in (B)
rotated by 180° with same panel arrangement as in (A).(D)
Model of second β-trefoil domain structure of hRyR1 (RyR-βD2)
in the same orientation as RyR-βD1 shown in (B).(E) View in (D)
rotate by 180°. Panel arrangement is the same as that in
(B). For more detail on the modeled structures of RyR-βD1 and
RyR-βD2 see Supplemental Figure S1. National Center for
Biotechnology Information (NCBI) accession numbers for sequences
used in the sequence alignment of RyRs are human RyR1 (J05200),
human RyR2 (X98330), human RyR3 (AJ001515), rabbit RyR1
(X15209), rabbit RyR2 (M59743), rabbit RyR3 (X68650), bull frog
RyR1 (D21070), bull frog RyR3 (D21071), fruit fly RyR (D17389),
and C. elegans RyR (D45899). Homology modeling was performed
using Modeller (Sali and Blundell, 1993). Conservation was
determined with ConSurf (Armon et al., 2001) and surface
representation was generated with GRASP (Nicholls et al., 1991)
(middle and bottom panels of [B]–[E]). PyMol (DeLano, 2002)
was used in top panels of (B)–(E).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2005,
17,
193-203)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.C.Tung,
P.A.Lobo,
L.Kimlicka,
and
F.Van Petegem
(2010).
The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule.
|
| |
Nature, 468,
585-588.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Wolfram,
E.Morris,
and
C.W.Taylor
(2010).
Three-dimensional structure of recombinant type 1 inositol 1,4,5-trisphosphate receptor.
|
| |
Biochem J, 428,
483-489.
|
 |
|
|
|
|
 |
G.E.Woodard,
J.J.López,
I.Jardín,
G.M.Salido,
and
J.A.Rosado
(2010).
TRPC3 regulates agonist-stimulated Ca2+ mobilization by mediating the interaction between type I inositol 1,4,5-trisphosphate receptor, RACK1, and Orai1.
|
| |
J Biol Chem, 285,
8045-8053.
|
 |
|
|
|
|
 |
V.Bauerová-Hlinková,
E.Hostinová,
J.Gasperík,
K.Beck,
L.Borko,
F.A.Lai,
A.Zahradníková,
and
J.Sevcík
(2010).
Bioinformatic mapping and production of recombinant N-terminal domains of human cardiac ryanodine receptor 2.
|
| |
Protein Expr Purif, 71,
33-41.
|
 |
|
|
|
|
 |
Z.Ding,
A.M.Rossi,
A.M.Riley,
T.Rahman,
B.V.Potter,
and
C.W.Taylor
(2010).
Binding of inositol 1,4,5-trisphosphate (IP3) and adenophostin A to the N-terminal region of the IP3 receptor: thermodynamic analysis using fluorescence polarization with a novel IP3 receptor ligand.
|
| |
Mol Pharmacol, 77,
995.
|
 |
|
|
|
|
 |
A.M.Rossi,
A.M.Riley,
S.C.Tovey,
T.Rahman,
O.Dellis,
E.J.Taylor,
V.G.Veresov,
B.V.Potter,
and
C.W.Taylor
(2009).
Synthetic partial agonists reveal key steps in IP3 receptor activation.
|
| |
Nat Chem Biol, 5,
631-639.
|
 |
|
|
|
|
 |
C.Li,
J.Chan,
F.Haeseleer,
K.Mikoshiba,
K.Palczewski,
M.Ikura,
and
J.B.Ames
(2009).
Structural Insights into Ca2+-dependent Regulation of Inositol 1,4,5-Trisphosphate Receptors by CaBP1.
|
| |
J Biol Chem, 284,
2472-2481.
|
 |
|
|
|
|
 |
C.W.Taylor,
T.Rahman,
S.C.Tovey,
S.G.Dedos,
E.J.Taylor,
and
S.Velamakanni
(2009).
IP3 receptors: some lessons from DT40 cells.
|
| |
Immunol Rev, 231,
23-44.
|
 |
|
|
|
|
 |
F.J.Amador,
S.Liu,
N.Ishiyama,
M.J.Plevin,
A.Wilson,
D.H.MacLennan,
and
M.Ikura
(2009).
Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation "hot spot" loop.
|
| |
Proc Natl Acad Sci U S A, 106,
11040-11044.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Anyatonwu,
and
S.K.Joseph
(2009).
Surface Accessibility and Conformational Changes in the N-terminal Domain of Type I Inositol Trisphosphate Receptors: STUDIES USING CYSTEINE SUBSTITUTION MUTAGENESIS.
|
| |
J Biol Chem, 284,
8093-8102.
|
 |
|
|
|
|
 |
P.A.Lobo,
and
F.Van Petegem
(2009).
Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations.
|
| |
Structure, 17,
1505-1514.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.C.Bandyopadhyay,
H.L.Ong,
T.P.Lockwich,
X.Liu,
B.C.Paria,
B.B.Singh,
and
I.S.Ambudkar
(2008).
TRPC3 controls agonist-stimulated intracellular Ca2+ release by mediating the interaction between inositol 1,4,5-trisphosphate receptor and RACK1.
|
| |
J Biol Chem, 283,
32821-32830.
|
 |
|
|
|
|
 |
I.I.Serysheva,
S.J.Ludtke,
M.L.Baker,
Y.Cong,
M.Topf,
D.Eramian,
A.Sali,
S.L.Hamilton,
and
W.Chiu
(2008).
Subnanometer-resolution electron cryomicroscopy-based domain models for the cytoplasmic region of skeletal muscle RyR channel.
|
| |
Proc Natl Acad Sci U S A, 105,
9610-9615.
|
 |
|
|
|
|
 |
X.Liu,
Z.Spicarová,
S.Rydholm,
J.Li,
H.Brismar,
and
A.Aperia
(2008).
Ankyrin B modulates the function of Na,K-ATPase/inositol 1,4,5-trisphosphate receptor signaling microdomain.
|
| |
J Biol Chem, 283,
11461-11468.
|
 |
|
|
|
|
 |
J.K.Foskett,
C.White,
K.H.Cheung,
and
D.O.Mak
(2007).
Inositol trisphosphate receptor Ca2+ release channels.
|
| |
Physiol Rev, 87,
593-658.
|
 |
|
|
|
|
 |
K.Mikoshiba
(2007).
IP3 receptor/Ca2+ channel: from discovery to new signaling concepts.
|
| |
J Neurochem, 102,
1426-1446.
|
 |
|
|
|
|
 |
M.Iwai,
T.Michikawa,
I.Bosanac,
M.Ikura,
and
K.Mikoshiba
(2007).
Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors.
|
| |
J Biol Chem, 282,
12755-12764.
|
 |
|
|
|
|
 |
S.K.Joseph,
and
G.Hajnóczky
(2007).
IP3 receptors in cell survival and apoptosis: Ca2+ release and beyond.
|
| |
Apoptosis, 12,
951-968.
|
 |
|
|
|
|
 |
C.White,
J.Yang,
M.J.Monteiro,
and
J.K.Foskett
(2006).
CIB1, a ubiquitously expressed Ca2+-binding protein ligand of the InsP3 receptor Ca2+ release channel.
|
| |
J Biol Chem, 281,
20825-20833.
|
 |
|
|
|
|
 |
H.Ando,
A.Mizutani,
H.Kiefer,
D.Tsuzurugi,
T.Michikawa,
and
K.Mikoshiba
(2006).
IRBIT suppresses IP3 receptor activity by competing with IP3 for the common binding site on the IP3 receptor.
|
| |
Mol Cell, 22,
795-806.
|
 |
|
|
|
|
 |
J.Y.Kim,
W.Zeng,
K.Kiselyov,
J.P.Yuan,
M.H.Dehoff,
K.Mikoshiba,
P.F.Worley,
and
S.Muallem
(2006).
Homer 1 mediates store- and inositol 1,4,5-trisphosphate receptor-dependent translocation and retrieval of TRPC3 to the plasma membrane.
|
| |
J Biol Chem, 281,
32540-32549.
|
 |
|
|
|
|
 |
K.Mikoshiba
(2006).
Inositol 1,4,5-trisphosphate IP(3) receptors and their role in neuronal cell function.
|
| |
J Neurochem, 97,
1627-1633.
|
 |
|
|
|
|
 |
S.Zhang,
S.Malmersjö,
J.Li,
H.Ando,
O.Aizman,
P.Uhlén,
K.Mikoshiba,
and
A.Aperia
(2006).
Distinct role of the N-terminal tail of the Na,K-ATPase catalytic subunit as a signal transducer.
|
| |
J Biol Chem, 281,
21954-21962.
|
 |
|
|
|
|
 |
W.Suhara,
M.Kobayashi,
H.Sagara,
K.Hamada,
T.Goto,
I.Fujimoto,
K.Torimitsu,
and
K.Mikoshiba
(2006).
Visualization of inositol 1,4,5-trisphosphate receptor by atomic force microscopy.
|
| |
Neurosci Lett, 391,
102-107.
|
 |
|
|
|
|
 |
Z.T.Schug,
and
S.K.Joseph
(2006).
The role of the S4-S5 linker and C-terminal tail in inositol 1,4,5-trisphosphate receptor function.
|
| |
J Biol Chem, 281,
24431-24440.
|
 |
|
|
|
|
 |
J.N.Wingard,
J.Chan,
I.Bosanac,
F.Haeseleer,
K.Palczewski,
M.Ikura,
and
J.B.Ames
(2005).
Structural analysis of Mg2+ and Ca2+ binding to CaBP1, a neuron-specific regulator of calcium channels.
|
| |
J Biol Chem, 280,
37461-37470.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|